Home > Journals > International Angiology > Past Issues > Articles online first > International Angiology 2022 Nov 23



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as



International Angiology 2022 Nov 23

DOI: 10.23736/S0392-9590.22.04952-5


language: English

Non-reversed bifurcated vein graft improves time to healing in ischemic patients undergoing lower limb distal bypass

Nicola TROISI 1 , Daniele ADAMI 1, Alberto PIAGGESI 2, Francesco CANOVARO 1, Letizia PIERUZZI 2, Lorenzo TORRI 1, Mauro FERRARI 1, Raffaella BERCHIOLLI 1

1 Unit of Vascular Surgery, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; 2 Section of Diabetic Foot, Department of Medicine, University of Pisa, Pisa, Italy


BACKGROUND: Bifurcated vein grafts have been described in reconstructive microsurgery. No comparative studies have been published in lower limb arterial revascularization. The aim of this study was to compare non-reversed bifurcated vs. single vein graft in patients with critical limb-threatening ischemia (CLTI) undergoing lower limb distal bypass.
METHODS: Between January 2015 and December 2021 193 CLTI patients have been treated at our center with vein bypass, and distal anastomosis on infrapopliteal vessels; 137 patients (71%) received a single graft (Group SIN), and 56 patients (29%) had a bifurcated bypass (Group BIF). Primary outcomes measures were time to healing, primary patency, primary assisted patency, secondary patency, and limb salvage. Two-year outcomes according to Kaplan-Meier curves were evaluated and compared.
RESULTS: Both groups were homogeneous in terms of demographic data, preoperative risk factors, and clinical presentation except for an elderly age in Group BIF (77.5 vs. 71.5 years; P<0.001). Intraoperative technical success was achieved in all patients. Overall median duration of follow-up was 19 months (interquartile range 9-36). Wound healing did not differ between the two groups (77.4% Group SIN vs. 73.2% Group BIF; P=0.33). Mean time to healing was faster in Group BIF (2.4 vs. 6.8 months; P<0.001). At 2-year follow-up there were no differences between the two groups in terms of primary patency (71.4% Group SIN vs. 54% Group BIF; P=0.10), primary assisted patency (81.7% Group SIN vs. 76.4% Group BIF; P=0.53), secondary patency (85.1% Group SIN vs. 80.9% Group BIF; P=0.79), and limb salvage (92.3% Group SIN vs. 87.2% Group BIF; P=0.64).
CONCLUSIONS: Bifurcated graft improved time to healing in CLTI patients undergoing infrapopliteal non-reversed vein bypass. Two-year overall patencies and limb salvage did not differ accordingly to vein graft configuration (single vs. bifurcated).

KEY WORDS: Chronic limb-threatening ischemia; Limb salvage; Saphenous vein

top of page